Good morning and welcome to Markets Desk.
Global bonds are extending their sell-off as inflation fears grip sovereign debt markets. US and Japanese yields pushed higher overnight, driven by investor anxiety over surging energy prices. The move signals that traders are repricing the duration risk they'd been willing to carry, and central banks are watching closely.
Turning to equities, GSK got a meaningful regulatory lift out of Tokyo. Japan's Ministry of Health expanded the eligible population for Arexvy, the company's RSV vaccine, to include adults aged eighteen to forty-nine who face elevated risk. That's a significant commercial expansion beyond the older-adult cohort where RSV vaccines have traditionally lived, and it broadens GSK's addressable market in one of the world's largest pharmaceutical economies.
And in media, Netflix is sitting on a number that would make any advertiser lean forward — two hundred fifty million monthly active viewers on its ad-supported tier. The challenge now is monetization. The streamer is leaning hard into live NFL games as its proof of concept, arguing that live sports command the premium CPMs that justify the pitch to brand buyers. Execution, not audience size, is the remaining question.
That's the tape. Markets Desk, signing off the floor.
